MoneyWorks4Me

The total revenue for the quarter ended June 2026 remained nearly unchanged at Rs. 18136.80 millions.A humble growth in net profit of 17.13% reported in the quarter ended June 2026 to Rs. 4285.20  millions from Rs. 3658.60 millions.Operating profit for the quarter ended June 2026 rose to 5978.70 millions as compared to 5184.30 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 18136.80 17383.50 4.33 18136.80 17383.50 4.33 69290.50 64091.50 8.11
Other Income 753.70 728.40 3.47 753.70 728.40 3.47 2881.40 2755.80 4.56
PBIDT 5978.70 5184.30 15.32 5978.70 5184.30 15.32 21802.20 19701.80 10.66
Interest 59.10 58.20 1.55 59.10 58.20 1.55 249.90 114.30 118.64
PBDT 5919.60 5126.10 15.48 5919.60 5126.10 15.48 21552.30 19587.50 10.03
Depreciation 197.50 194.80 1.39 197.50 194.80 1.39 759.60 718.00 5.79
PBT 5722.10 4931.30 16.04 5722.10 4931.30 16.04 20792.70 18869.50 10.19
TAX 1436.90 1272.70 12.90 1436.90 1272.70 12.90 5272.50 4725.10 11.58
Deferred Tax -31.80 -5.00 536.00 -31.80 -5.00 536.00 -107.20 27.20 -494.12
PAT 4285.20 3658.60 17.13 4285.20 3658.60 17.13 15520.20 14144.40 9.73
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 32.96 29.82 10.53 32.96 29.82 10.53 31.46 30.74 2.36

Abbott India Share Price

27076.90 -540.55 (-1.96%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: